Journal of the Association of European Psychiatrists This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The new European Medicines Agency guideline on antidepressants: a guide for researchers and drug developers
Eur Psychiatry. 2023 Dec 15;67(1):e2. doi: 10.1192/j.eurpsy.2023.2479.ABSTRACTAccording to the World Health Organization (WHO), depressive disorders are currently considered as one of the most disabling medical conditions in the world with one of the highest disability-adjusted life years [1] and this situation has apparently been further worsened during the COVID-19 pandemic [2]. Up to two thirds of patients with major depressive disorders (MDD) do not achieve full remission following an adequate first line standard of care and/or experience residual symptoms such as anxiety, impaired cognition, fatigue, sleep disturbance...
Source: Journal of the Association of European Psychiatrists - December 15, 2023 Category: Psychiatry Authors: Florence Butlen-Ducuing Marion Haberkamp Georgios Aislaitner Ewa Ba łkowiec-Iskra Taina Mattila Marika Doucet Marta Kollb-Sielecka Pavel Balabanov Ann-Kristin Leuchs Andr é Elferink Source Type: research

The new EMA guideline on antidepressants: A guide for researchers and drug developers
Eur Psychiatry. 2023 Dec 15:1-4. doi: 10.1192/j.eurpsy.2023.2479. Online ahead of print.NO ABSTRACTPMID:38098366 | DOI:10.1192/j.eurpsy.2023.2479 (Source: Journal of the Association of European Psychiatrists)
Source: Journal of the Association of European Psychiatrists - December 15, 2023 Category: Psychiatry Authors: Florence Butlen-Ducuing Marion Haberkamp Georgios Aislaitner Ewa Ba łkowiec-Iskra Taina Mattila Marika Doucet Marta Kollb-Sielecka Pavel Balabanov Ann-Kristin Leuchs Andr é Elferink Source Type: research